digplanet beta 1: Athena
Share digplanet:

Agriculture

Applied sciences

Arts

Belief

Business

Chronology

Culture

Education

Environment

Geography

Health

History

Humanities

Language

Law

Life

Mathematics

Nature

People

Politics

Science

Society

Technology

G. V. Prasad
జి.వి. ప్రసాద్
Residence Hyderabad, India
Nationality Indian
Ethnicity Telugu, Andhraite
Alma mater Purdue University
Illinois Institute of Technology
Alagappa College of Technology
Occupation CEO of Dr. Reddy's Laboratories
Religion Hindu
Relatives Kallam Anji Reddy (father-in-law)
Kallam Satish Reddy (brother-in-law)

G. V. Prasad (Telugu: జి.వి. ప్రసాద్) is an Indian business executive, and CEO of Dr. Reddy's Laboratories.[1][2] Prasad studied Chemical Engineering at the Alagappa College of Technology. After completing five semesters, he went on to the Illinois Institute of Technology in Chicago to complete the three remaining semesters. Prasad followed up the engineering degree with a one year MBA at Purdue University. He won the 'Outstanding Senior Student' Award from the American Institute of Chemists, Chicago chapter in 1982. He earned his Masters in Industrial Administration from Purdue University a year later. [3]

His first exposure to the world of pharmaceuticals was in 1985 with Benzex Labs, a pharmaceutical enterprise that he co-founded. Benzex was later acquired by Dr. Reddys and Prasad returned to the construction business, only to come back to pharmaceuticals in 1990 – this time as the CEO and MD of Cheminor Drugs Ltd. In 2001, Cheminor Drugs merged with Dr.Reddy's Laboratories[4] and Prasad took over as the vice-chairman and CEO of the merged entity.[5]

Early life[edit]

Prasad, the second child of Syamala and Harischandra Reddy, did his initial schooling at the Vidyaranya High School in Hyderabad, Andhra Pradesh, India. He later moved to his hometown, Nellore, where he finished his schooling at VR High School.[6]

Personal life[edit]

Prasad is married to Anuradha, the daughter of Kallam Anji Reddy, who is the founder of Dr Reddy's Labs.[7] Anuradha is the managing trustee of Dr Reddy's Foundation as well as the founder-director of Saptaparni, an organisation promoting the traditions and culture of India.[8]

Early career[edit]

After completing his Masters, Prasad returned to India and joined his father's construction business, immersing himself in various projects in Karnataka. In 1985, he co-founded Benzex Labs, an API manufacturing company, which was later acquired by Dr Reddy's. He briefly returned to the construction business before reappearing on the pharma landscape in 1990 as managing director of Cheminor Drugs Ltd. Fueled by a spirit of entrepreneurship, Prasad transformed Cheminor into a world class API and Generics manufacturer, largely through his focus on professionalism, good governance and transparency.

In 2001, Cheminor Drugs merged with Dr.Reddy's Laboratories and Prasad took over as the vice-chairman and CEO of the merged entity. Prasad is widely credited as the architect of Dr. Reddy's successful global generics strategy. He envisioned newer business platforms like the Custom Pharmaceutical business and Specialty pharmaceuticals and is dedicated to building the innovation side of the business.

Professional affiliations[edit]

  • AP State Committee, WWF-India
  • Member of the Advisory Board, Acumen Fund
  • Member of the Board, Infotech Enterprises Ltd.
  • Member of the Board, Diana Hotels, India
  • Member of the Board, Ocimum Bio Solutions
  • Member, American Chemical Society
  • Member, American Institute of Chemical Engineers
  • Served as Chairman of the CII National Committee on Environment and the Intellectual Property Committee (2006–2007)

References[edit]

External links[edit]


Original courtesy of Wikipedia: http://en.wikipedia.org/wiki/G._V._Prasad — Please support Wikipedia.
This page uses Creative Commons Licensed content from Wikipedia. A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.

294 news items

Livemint

Livemint
Wed, 25 Mar 2015 22:48:45 -0700

... to acquire dermatology or migraine medication brands, companies that give it access to new technology like drug delivery systems or nanotechnology, and those that give it more access to markets in Latin America, chief executive officer G.V. Prasad ...

FiercePharma

FiercePharma
Thu, 26 Mar 2015 09:18:45 -0700

It's also eyeing deals that would build up its presence in Latin America, CEO G.V. Prasad told Bloomberg. Dr. Reddy's is up for a set of small acquisitions or bigger deals worth as much as $1 billion, Chief Financial Officer Saumen Chakraborty added ...

The New Indian Express

The New Indian Express
Mon, 23 Mar 2015 15:38:15 -0700

... with Dr Reddy's philosophy of offering 'innovative medicine at an affordable price' and will provide significant relief to patients, resulting in potential cure and a high barrier to resistance at an affordable price for those living with Hepatitis ...

Business Today

Business Today
Fri, 28 Nov 2014 08:24:21 -0800

He is just back from the Sundarbans with a host of pictures of the world's largest tidal halophytic mangrove forest, taken with his new Canon 5D Mark III camera. G.V. Prasad, Co-Chairman and CEO of the $2.2-billion Dr. Reddy's Laboratories , has been a ...
 
Economic Times
Tue, 23 Sep 2014 14:23:15 -0700

In an exclusive interview to ET, Chief Executive Officer G V Prasad opens up about how "jugaad" attitude caused lapses among few Indian drug makers, leading US Food & Drug Administration to impose curbs on some plants. Edited excerpts from the ...

Livemint

Livemint
Mon, 24 Nov 2014 11:07:30 -0800

G.V. Prasad is co-chairman and chief executive officer (CEO) of Dr Reddy's Laboratories Ltd, India's largest pharmaceutical company by turnover. The firm he heads has over 16,000 employees across the world, and manufactures 190 medications and 60 ...
 
Myiris.com
Mon, 23 Mar 2015 04:03:45 -0700

Dr Reddy's co-chairman & CEO, G V Prasad, commented, ''the launch of Resof is in line with Dr Reddy's philosophy of ''Innovative medicine at an affordable price'' and will provide significant relief to patients, resulting in potential cure and a high ...

Moneycontrol.com

Indiainfoline
Mon, 12 Jan 2015 03:37:30 -0800

In an interview with CNBC TV18, GV Prasad, Co-Chairman & CEO, Dr. Reddy's Laboratories, said that the currency fluctuation will impact the topline and bottomline both because the value of the sale will come down but the company has some hedges which ...
Loading

Oops, we seem to be having trouble contacting Twitter

Support Wikipedia

A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia. Please add your support for Wikipedia!

Searchlight Group

Digplanet also receives support from Searchlight Group. Visit Searchlight